mschwarz	10.1158/1535-7163.MCT-13-0361	<http://dx.doi.org/10.1158/1535-7163.mct-13-0361>; rel="canonical", <https://syndication.highwire.org/content/doi/10.1158/1535-7163.MCT-13-0361>; version="vor"; rel="item"	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:j.0="http://purl.org/dc/terms/" xmlns:j.1="http://prismstandard.org/namespaces/basic/2.1/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:j.2="http://purl.org/ontology/bibo/" xmlns:j.3="http://xmlns.com/foaf/0.1/"><rdf:Description rdf:about="http://dx.doi.org/10.1158/1535-7163.MCT-13-0361"><j.0:isPartOf><j.2:Journal rdf:about="http://id.crossref.org/issn/1535-7163"><j.1:issn>1538-8514</j.1:issn><j.2:issn>1538-8514</j.2:issn><owl:sameAs>urn:issn:1538-8514</owl:sameAs><owl:sameAs>urn:issn:1535-7163</owl:sameAs><j.0:title>Molecular Cancer Therapeutics</j.0:title><j.1:issn>1535-7163</j.1:issn><j.2:issn>1535-7163</j.2:issn></j.2:Journal></j.0:isPartOf><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/m-a-schwarz-1090ji59nd02q"><j.3:name>M. A. Schwarz</j.3:name><j.3:familyName>Schwarz</j.3:familyName><j.3:givenName>M. A.</j.3:givenName></j.3:Person></j.0:creator><j.2:pageEnd>1043</j.2:pageEnd><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/r-e-schwarz-1090ji59nd02q"><j.3:name>R. E. Schwarz</j.3:name><j.3:familyName>Schwarz</j.3:familyName><j.3:givenName>R. E.</j.3:givenName></j.3:Person></j.0:creator><j.1:startingPage>1032</j.1:startingPage><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/a-m-schwarz-1090ji59nd02q"><j.3:name>A. M. Schwarz</j.3:name><j.3:familyName>Schwarz</j.3:familyName><j.3:givenName>A. M.</j.3:givenName></j.3:Person></j.0:creator><j.0:identifier>10.1158/1535-7163.mct-13-0361</j.0:identifier><j.1:doi>10.1158/1535-7163.mct-13-0361</j.1:doi><j.2:doi>10.1158/1535-7163.mct-13-0361</j.2:doi><j.1:volume>13</j.1:volume><j.0:date rdf:datatype="http://www.w3.org/2001/XMLSchema#date" >2014-03-07</j.0:date><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/n-awasthi-1090ji59nd02q"><j.3:name>N. Awasthi</j.3:name><j.3:familyName>Awasthi</j.3:familyName><j.3:givenName>N.</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/c-zhang-1090ji59nd02q"><j.3:name>C. Zhang</j.3:name><j.3:familyName>Zhang</j.3:familyName><j.3:givenName>C.</j.3:givenName></j.3:Person></j.0:creator><j.2:pageStart>1032</j.2:pageStart><owl:sameAs rdf:resource="doi:10.1158/1535-7163.mct-13-0361"/><owl:sameAs rdf:resource="info:doi/10.1158/1535-7163.mct-13-0361"/><owl:sameAs rdf:resource="http://dx.doi.org/10.1158/1535-7163.mct-13-0361"/><j.0:publisher>American Association for Cancer Research (AACR)</j.0:publisher><j.1:endingPage>1043</j.1:endingPage><j.2:volume>13</j.2:volume><j.0:title>Enhancement of Nab-Paclitaxel Antitumor Activity through Addition of Multitargeting Antiangiogenic Agents in Experimental Pancreatic Cancer</j.0:title><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/s-hinz-1090ji59nd02q"><j.3:name>S. Hinz</j.3:name><j.3:familyName>Hinz</j.3:familyName><j.3:givenName>S.</j.3:givenName></j.3:Person></j.0:creator></rdf:Description></rdf:RDF>
